About
Entering the U.S. healthcare market requires more than a strong product. International HealthTech companies must align legal structure, compliance, reimbursement, and go-to-market strategy with how and where they plan to grow. This workshop helps founders evaluate U.S. market entry through commercial and legal lenses. Using real-world examples, payer and reimbursement pathways, state-level differences, and operating structures, the session shows leaders how to make informed decisions about where to launch, who to sell to, and what infrastructure can support growth. You’ll learn how to: 🇺🇸 Identify U.S. market-entry pathways based on your solution and target customer 💰 Evaluate payer, employer, provider, government, and direct-to-consumer opportunities 🗺️ Compare state-level differences that affect reimbursement, costs, and market entry ⚖️ Connect legal structure, compliance, and corporate-practice rules to commercialization 🏢 Evaluate when no U.S. presence, an LLC, or a Delaware C Corporation may fit your strategy 📈 Build a focused go-to-market approach that supports contracts, investment, and scale --------------------------------------------------------- Dennis M. Sponer, JD, LLM, TRIUM MBA Dennis is an attorney, healthcare entrepreneur, and founder of SRX Advisors. He co-founded ScripNet, a pharmacy benefit manager later acquired by Healthcare Solutions, now Optum Healthcare Solutions, and later founded and sold HSARx. Demi Radeva, MSc Demi is the founder of Akros Advisory and a former UnitedHealthcare and Optum leader across Medicaid, Medicare, and Commercial health plans. She has supported 50+ HealthTech startups with payer strategy, market access, funding, and payer contracts. --------------------------------------------------------- Best for: International HealthTech founders, digital health and MedTech leaders, commercial and market access teams, and companies entering or expanding in the U.S.